Page last updated: 2024-10-18

dalteparin and Hepatitis

dalteparin has been researched along with Hepatitis in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Hepatitis: INFLAMMATION of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"In human patients with liver cirrhosis, portal vein thrombosis (PVT) is a common complication."1.62Long-term follow-up of portal vein thrombosis in an American Cocker Spaniel with lobular dissecting hepatitis: a case report. ( Ishikawa, C; Kagawa, Y; Nakayama, T; Sakai, M; Sakamoto, Y; Sato, K, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sakamoto, Y1
Sato, K1
Ishikawa, C1
Kagawa, Y1
Nakayama, T1
Sakai, M1

Other Studies

1 other study available for dalteparin and Hepatitis

ArticleYear
Long-term follow-up of portal vein thrombosis in an American Cocker Spaniel with lobular dissecting hepatitis: a case report.
    BMC veterinary research, 2021, Sep-30, Volume: 17, Issue:1

    Topics: Animals; Anticoagulants; Computed Tomography Angiography; Dalteparin; Dog Diseases; Dogs; Follow-Up

2021